Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2021 Sep 8;21(10):38.
doi: 10.1007/s11892-021-01404-5.

Association Between Diabetes, Diabetic Retinopathy, and Glaucoma

Yangjiani Li  1   2 , William Mitchell  3   4 , Tobias Elze  1 , Nazlee Zebardast  5   6
Affiliations
Review

Association Between Diabetes, Diabetic Retinopathy, and Glaucoma

Yangjiani Li et al. Curr Diab Rep. .

Abstract

Purpose of review: The strength of the relationship between diabetes, diabetic retinopathy (DR), and glaucoma remains controversial. We review evidence supporting and refuting this association and explore mechanistic pathological and treatment relationships linking these diseases.

Recent findings: While studies have shown diabetes/DR may increase the risk for glaucoma, this remains inconsistently demonstrated. Diabetes/DR may contribute toward glaucomatous optic neuropathy indirectly (either by increasing intraocular pressure or vasculopathy) or through direct damage to the optic nerve. However, certain elements of diabetes may slow glaucoma progression, and diabetic treatment may concurrently be beneficial in glaucoma management. Diabetes plays a significant role in poor outcomes after glaucoma surgery. While the relationship between diabetes/DR and glaucoma remains controversial, multiple mechanistic links connecting pathophysiology and management of diabetes, DR, and glaucoma have been made. However, a deeper understanding of the causes of disease association is needed.

Keywords: Clinical trial; Diabetes; Diabetic retinopathy; Glaucoma; Mechanism; POAG.

PubMed Disclaimer

References

Papers of particular interest, published recently, have been highlighted as: • Of importance
    1. Tham Y, et al. Global prevalence of glaucoma and projections of glaucoma burden through 2040. Ophthalmology. 2014;121(11):2081–90. https://doi.org/10.1016/j.ophtha.2014.05.013 . - DOI - PubMed
    1. Wang HW, et al. Research progress on human genes involved in the pathogenesis of glaucoma (Review). Mol Med Rep. 2018;18(1):656–74. https://doi.org/10.3892/mmr.2018.9071 . - DOI - PubMed - PMC
    1. K, B. Who is at risk for glaucoma? American Academy of Ophthalmology. 2020. https://www.aao.org/eye-health/diseases/glaucoma-risk . Accessed Jan 2021.
    1. Glaucoma tables. National Eye Institute. 2020. https://www.nei.nih.gov/learn-about-eye-health/resources-for-health-educ... . Accessed Jan 2021.
    1. Actis AG, et al. An internal medicine perspective review of risk factors for assessing and progression of primary open angle glaucoma. Minerva Med. 2013;104(4):471–85. - PubMed

Publication types

LinkOut - more resources